Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666918 | SCV000791291 | likely pathogenic | Pyknodysostosis | 2017-05-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002530701 | SCV003523508 | pathogenic | not provided | 2023-05-30 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the CTSK mRNA. The next in-frame methionine is located at codon 75. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the CTSK protein in which other variant(s) (p.Arg46Trp) have been determined to be pathogenic (PMID: 17206399, 24269275, 27092432). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 551777). Disruption of the initiator codon has been observed in individual(s) with pycnodysostosis (PMID: 24767306). This variant is present in population databases (rs778368118, gnomAD 0.003%). |
Genome- |
RCV000666918 | SCV004049737 | likely pathogenic | Pyknodysostosis | 2023-04-11 | criteria provided, single submitter | clinical testing |